Harshabad Singh, Program Director Hepatobiliary and Pancreas Cancers at Mass general Brigham, shared by Mass General Brigham, on LinkedIn:
“To mark this historic time in the treatment of pancreatic cancer it is a pleasure to announce the Inaugural Mass General Brigham Cancer Institute Pancreatic Cancer Symposium, which we will host on November 18, 2026, during Pancreatic Cancer Awareness Month. The symposium will highlight some of the most innovative work in pancreatic cancer happening across Mass General Brigham and bring together investigators, clinicians, patients, and advocates to consider our collective path forward.
A tremendous amount of work has gone on behind the scenes with my fellow symposium co-organizers Motaz Qadan, Thomas Clancy, David Ting, William Hwang, Harshabad Singh, Jennifer Wo.
We are especially honored that Dr. Liz Jaffee agreed to deliver the Keynote Lecture for the symposium. Liz is a mentor and a leader in our field who has led cutting-edge work across so many aspects of pancreatic cancer, including early detection, immunotherapy, vaccines, and cancer interception. We are thrilled to have her join us for our inaugural symposium!
The symposium will also feature an interactive session reflecting on the journey of our patients, led by Dr. Jennifer Wo.
We are excited to welcome Dr. Anna Berkenblit from the Pancreatic Cancer Action Network for this session, Beyond Treatment: Patient Perspectives on Pancreatic Cancer.
There is extraordinary momentum in pancreatic cancer right now. Our hope is that this symposium brings together the science, clinical advances, and, most importantly, the experiences of our patients to help define what comes next.
For more details and free registration.”
Quoting Mass General Brigham:
“Mass General Brigham Cancer Institute is excited to offer patients daraxonrasib, a groundbreaking new treatment for pancreatic cancer. Only weeks after this practice-changing therapy moved beyond clinical trials, our team began administering it through a carefully coordinated process designed to ensure safe access for patients.
Mary Linton Peters a medical oncologist at Mass General Brigham Cancer Institute, discusses the significance of bringing this promising treatment to patients as quickly as possible. The Boston Globe Media chronicles Lazar Mandinov’s journey as he took daraxonrasib for the first time.”
Other articles about Pancreatic Cancer on OncoDaily.